Literature DB >> 11244147

Psychosocial correlates of suicidal intent among patients with schizophrenia.

R C Schwartz1, B N Cohen.   

Abstract

Suicidal intent is common among patients with schizophrenia, resulting in extreme personal distress, increased hospitalizations and healthcare expenditures, and early mortality. However, the psychosocial correlates of current suicidality among schizophrenic patients are not fully understood. This study attempted to identify psychosocial correlates of current suicidal intent in a sample of 267 patients with schizophrenia. Multiple regression analyses were used to assess the relationship between suicidality and current symptomatology, psychosocial problems, global functioning, and demographic characteristics. Results showed that depressive symptomatology as a single variable accounted for approximately 50% of the variance in ratings of suicidal intent. In addition, female gender, younger age, recent traumatic stress, and less severe psychotic symptoms each significantly predicted current suicidality independent of depressive symptoms. The combination of depression among younger female schizophrenic patients whose psychotic symptoms have abated and who are experiencing current traumatic stress may indicate extreme suicidal intent. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Year:  2001        PMID: 11244147     DOI: 10.1053/comp.2001.21222

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  10 in total

Review 1.  Elderly patients with schizophrenia and depression: diagnosis and treatment.

Authors:  Kandi Felmet; Sidney Zisook; John W Kasckow
Journal:  Clin Schizophr Relat Psychoses       Date:  2011-01

2.  Suicidal behavior in adolescents with first-episode psychosis.

Authors:  Tatiana Falcone; Leenu Mishra; Erin Carlton; Catherine Lee; Robert S Butler; Damir Janigro; Barry Simon; Kathleen Franco
Journal:  Clin Schizophr Relat Psychoses       Date:  2010-04

3.  Differing correlates for suicide attempts among patients with schizophrenia or schizoaffective disorder in India and USA.

Authors:  Triptish Bhatia; Pramod Thomas; Prachi Semwal; B K Thelma; V L Nimgaonkar; Smita N Deshpande
Journal:  Schizophr Res       Date:  2006-06-15       Impact factor: 4.939

4.  Case-control study of the relationship of depressive symptoms to suicide in a community-based sample of individuals with schizophrenia in China.

Authors:  John Kasckow; Nancy Liu; Gretchen L Haas; Michael R Phillips
Journal:  Schizophr Res       Date:  2010-03-12       Impact factor: 4.939

5.  Subjective quality of life and suicidal behavior among Taiwanese schizophrenia patients.

Authors:  Yu-Chen Kao; Yia-Ping Liu; Tsung-Hsing Cheng; Ming-Kuen Chou
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-03-10       Impact factor: 4.328

Review 6.  Co-occurring depressive symptoms in the older patient with schizophrenia.

Authors:  John W Kasckow; Sidney Zisook
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

7.  Lurasidone for the treatment of depressive symptoms in schizophrenia: analysis of 4 pooled, 6-week, placebo-controlled studies.

Authors:  Henry A Nasrallah; Josephine B Cucchiaro; Yongcai Mao; Andrei A Pikalov; Antony D Loebel
Journal:  CNS Spectr       Date:  2014-06-23       Impact factor: 3.790

8.  Severity of psychotic episodes in predicting concurrent depressive and anxiety features in acute phase schizophrenia.

Authors:  Kalai Naidu; Werdie C W van Staden; Mike van der Linde
Journal:  BMC Psychiatry       Date:  2014-06-05       Impact factor: 3.630

9.  Discerning undifferentiated anxiety from syndromal anxiety in acute-phase schizophrenia.

Authors:  Kalai Naidu; Werdie van Staden; Lizelle Fletcher
Journal:  Ann Gen Psychiatry       Date:  2020-04-15       Impact factor: 3.455

Review 10.  Worldwide prevalence of suicidal ideation and suicide plan among people with schizophrenia: a meta-analysis and systematic review of epidemiological surveys.

Authors:  W Bai; Z H Liu; Y Y Jiang; Q E Zhang; W W Rao; T Cheung; B J Hall; Y T Xiang
Journal:  Transl Psychiatry       Date:  2021-10-29       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.